Blood-borne Disease Research
Trust the validity of your data
ATCC's expanding portfolio of fully authenticated and characterized products support research on sepsis and a variety of infectious and genetic blood-borne diseases.
ATCC cultures and nucleic acids are supported by a polyphasic approach that combines phenotypic, genotypic, proteotypic, and functional analyses to ensure authenticity. Moreover, ATCC products are produced under ISO 9001:2008 certified and ISO/IEC 17025:2005 accredited processes, so you can trust your results and reproduce your data. Browse our blood-borne disease research solutions using the links provided below, or:
Download our white paper to discover ways to overcome key challenges during the development and validation of molecular-based assays!
In an effort to support the development of additional molecular-based tools designed for preventing the spread of blood-borne pathogens during transplantation, ATCC offers a variety of quantitative synthetic and genomic nucleic acids representing microorganisms know to be transmitted via infected blood.
Browse our nucleic acids
Strains Isolated from Blood
ATCC offers a number of microorganisms isolated from blood samples. These strains are ideal for evaluating the inclusivity and exclusivity of assays designed to detect and quantify blood-borne pathogens.
Explore our strains
Elevate your blood cancer research with cell lines and cell culture reagents focused on advancing areas such as leukemia, lymphoma, and myeloma. Our collection includes immune cells, CD34+ and CD14+ progenitor cells, PBMCs, lymphocytes, and leukocytes.